#Synthetic Biology

Lead report

Piper Sandler Maintains Overweight Rating on Twist Bioscience Amid Cautious Tools Sector

Piper Sandler reiterates its Overweight rating on Twist Bioscience, highlighting the company's DNA synthesis platform and long-term growth potential despite a cautious outlook for the life science tools sector.